Joan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.
Linda told me the too often heard story of a routine chest x-ray before surgery, and suddenly, the anxiety over having a gallbladder removed was overshadowed by the news that the x-ray revealed a large lung mass.
Suzanne Somers had her critics, but many applauded her approach to health care and cancer.
PD-L1 status may not be the best predictor when it comes to determining who will respond to checkpoint blockade.
Further evidence strengthens the support of mirvetuximab soravtansine as a new standard of care for folate receptor-alpha—positive ovarian cancer resistant to platinum chemotherapy.
Dr. Elena Ratner discusses the interaction between menopause and certain treatments for breast cancer.
Nivolumab plus gemcitabine-cisplatin improved overall and progression-free survival in unresectable or metastatic urothelial carcinoma.
Pamela Devine, RN, clinical nurse specialist, Philadelphia Veterans Administration Medical Center, discusses some of the psychosocial issues that men face when they are receiving treatment for their prostate cancer.
A guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.
Caregivers of young adult survivors (YAS) of childhood brain tumors, usually their mothers, live dramatically altered lives as they incorporate illness management into family life and function in caregiving roles well into the survivors’ adulthood.
Choosing frontline therapy for patients with metastatic non–small cell lung cancer (NSCLC) who do not harbor an actionable driver oncogene depends upon PD-L1 expression level and histology, according to Gregory J. Riely, MD, PhD.
Jae Park, MD, hematologist-oncologist, Memorial Sloan Kettering Cancer Center, talks about CAR T-cell activation therapy, which is currently in clinical trials for patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma.
Olga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.
Kim Christen, RN, BSN, OCN, of Kootenai Clinic Cancer Services discusses the process of creating a protocol for the onsite pharmacy at Kootenai that keeps patients at the center.
A recent study presented at the 2017 Genitourinary Cancers Symposium found that use of antibiotics could damper the efficacy of checkpoint inhibitors, potentially due to the relationship between gut microbiota and antibiotics.
After the widespread use of targeted therapies for breast cancer treatment, there was a wider gap in mortality rates between black and white women with the disease.
Mindfulness can be a powerful tool to reduce stress and improve patients' outlook after being diagnosed with cancer.
Patricia Kropf, MD, assistant professor, Division of Bone Marrow Transplants, Fox Chase Cancer Center, discusses home administration of Synribo (omacetaxine mepesuccinate).
Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.
Carolyn Phillips, MSN, RN, ACNP-BC, AOCNP, University of Texas at Austin, School of Nursing, discusses her program for nurses, Songs for the Soul
Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.
Tobacco use among young people is an old problem that now challenges a new generation in a new form: vaping.
With the emphasis on testing for biomarkers to determine treatment for patients with lung cancer, it's important to make sure the testing will have an impact on clinical decisions.
A form of T-cell (non-Hodgkin) lymphoma known as breast implant associated anaplastic large-cell lymphoma (BIA-ALCL) has been noted as a rare association with the implant-based approach of reconstructive surgery post mastectomy.
Accelerated partial breast irradiation (APBI) using multicatheter brachytherapy in patients with early-stage breast cancer was not inferior to conventional whole breast irradiation (WBI), according to a phase III study presented at the 2015 American Society for Radiation Oncology (ASTRO) Annual Meeting.
Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center (MSK), discusses a study investigating the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
Barbara Daly, PhD, RN, FAAN, and Helen Foley, MSN, AOCNS®, offer highlights of their institution's oncology and palliative care program, which successfully prepares graduates to assume advanced practice roles in these important areas.
I am used to it now, the chuckles and candid references to compasses and aviation from some and the grateful looks from others, as though I have just extended them a lifeline.